We are live on
!
Find out more
FOLD
Amicus Therapeutics
FOLD
FOLD
Delisted
FOLD was delisted on the 24th of April, 2026.
217 hedge funds and large institutions have $2.81B invested in Amicus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 87 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
19% less capital invested
Capital invested by funds: $3.48B → $2.81B (-$666M)
26% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 87
Holders
217
Holding in Top 10
6
Calls
$3.56M
Puts
$2.56M
Top Buyers
| 1 | +$54.1M | |
| 2 | +$33.6M | |
| 3 | +$18.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$13.4M |
| 5 |
PA
Perceptive Advisors
New York
|
+$9.34M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$18.8M | |
| 3 | -$17M | |
| 4 |
GH
Grosvenor Holdings
Chicago,
Illinois
|
-$11.1M |
| 5 |
Two Sigma Investments
New York
|
-$11.1M |